[UK] +44 (0)1304 892398 [US] +19782 899035 admin@trn.net
Philip Hedge

Philip Hedge

Philip Hedge Philip Hedge (PhD) is a bioscientist with 24 years of experience of cancer drug discovery at AstraZeneca. Philip has conducted and led research across all phases of research, including new target discovery, lead generation,...
Miri Seiberg

Miri Seiberg

Miri Seiberg Miri Seiberg is a life sciences R&D expert with a track record of research innovation. She has initiated and managed research and development programs in the fields of skin and mucosal tissue biology, resulting in novel drug candidates and successful...
Pirthipal Singh

Pirthipal Singh

Pirthipal Singh Pirthipal joined ICI in Dec 1978 (Natural Products Group) as an Experimental Officer, after graduating in Biochemistry from University of Leeds. He developed a range of radioligand binding assays and subsequently established the concept of high...
Andrew Charles

Andrew Charles

Andrew Charles Andrew has more than 25 years experience in the pharmaceutical industry across all phases of drug discovery from early target identification and validation to late PhIIb. During his career in AstraZeneca, Andrew has worked as a bioscientist in several...

Privacy Preference Center

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?